Orphazyme - first trading day on the Copenhagen Stock Exchange on 16 November 2017!

16 November 2017

From the tentative preparation of the first patent application, to stock exchange listing and clinical trials – HØIBERG is along all the way! 

Many congratulations to our client Orphazyme - and we wish them good luck with the first stock exchange listing of a biotech company since 2010!

The listing will finance the next years clinical trials with the drug candidate arimoclomol in connection with rare diseases.